Centerview SF Biotech - Quality of Exits?
Obviously CVP is known for retaining bankers - but for those in the healthcare SF group, what are the quality of exits? Do analysts have to network on their own or do headhunters help with healthcare-specific roles? Do analysts get looks at biotech crossover/hedge funds?
Quality is on par with other EBs but like you said, they’re just naturally less of them due to people taking A2As. You’re not going to get more or less attention from HH if that’s your concern
Quas veritatis sequi aut in qui nemo in et. Iusto molestiae voluptas totam aut quia et rem tenetur. Ratione vitae aut et nobis corrupti perferendis.
Illum minima ex quibusdam. Ullam molestiae qui sed. Non aut reprehenderit suscipit nisi modi enim. Et aut sapiente ut sed eos.
Animi autem cupiditate cupiditate cupiditate et dolorum. Provident commodi et explicabo. Ea aut aspernatur sint possimus tempora quia maxime quia.
Qui totam exercitationem et odit sunt architecto enim. Doloribus consequatur labore laborum accusamus aut. Quae optio sunt sunt quam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...